2004; ajnek unpublished), become rebuilt into cyclin D3CDK4p27 complexes (Savatieretal

2004; ajnek unpublished), become rebuilt into cyclin D3CDK4p27 complexes (Savatieretal. cyclin D1/D2CDK4p27 complexes. Differentiation is definitely accompanied by cytoplasmic build up of cyclin Ds and CDK4/6, which in neural cells are associated with neural outgrowths. Most phenomena found here can be reproduced in mouse embryonic stem cells. In summary, our data demonstrate (i) that individual cyclin D isoforms are utilized in cells lineage specifically, (ii) that fundamental difference in the function of CDK4 and CDK6 is present, and (iii) that cyclin DCDK4/6 complexes function in the cytoplasm of differentiated cells. Our study unravels another level of difficulty in G1/S transitionregulating machinery in early embryonic cells. == Intro == During development of multicellular organisms, cell lineages become specified, cells acquire unique cell fates, and they differentiate. Differentiation processes proceed inside a balanced concerted way, with cell proliferation and cell death keeping homeostasis of the entire organism. At least some differentiation processes can be efficiently mimickedin vitrousing pluripotent embryonic stem (Sera) and embryonal carcinoma (EC) cells, which have their physiologicalin vivocounterparts in cells of preimplantation embryos (Andrewset al. 2001;Smith 2001). Cyclindependent kinases (CDKs), their activating and inhibiting partners cyclins and CDK inhibitors (CKIs), are well recognized as essential regulators of cell proliferation. Their relationships, activities and functions as related to rules of both progression of the cell cycle and maintenance of the quiescent state are well established (for evaluations, seeSherr 1995;Sherr Rhosin & Roberts 1999). Yet, irrespective of whether the cells reside in a developing embryo or in an adult organism, manifestation of individual cell cycle regulators of G1and S phases is significantly varied, with individual cell types utilizing specific G1/S cell cycle regulators to guarantee a balance between proliferation, quiescence, and/or maintenance of differentiation (for evaluations, seeGao & Zelenka 1997;Nakayama & Nakayama 1998). In this study, mouse embryonal carcinoma cells (collection P19) have been employed to address the query of how such molecular diversification evolves during the earliest methods of differentiation that take place in the early embryo. Up until now, severalin vitrostudies have been undertaken with the aim of understanding the part of cell cycle regulators in early differentiation; however, their results are not completely congruent (Savatieret al. 1995;Gillet al. 1998;Baldassarreet al. 1999;Liet al. 1999;Watanabeet al. 1999;Baldassarreet al. 2000;Glozak & Rogers 2001;Preclikovaet al. 2002;Bryjaet al. 2004b;Bryjaet al. 2005). Still, as tradition systems (monolayer versus threedimensional), differentiationinducing strategy/compounds, timing, cell denseness and other factors vary from study to study, controversies are likely to some extent, due to variations in experimental setup. Here, to conquer such limitations, we have introduced a simple experimental design Rhosin that uses P19 EC cells, which earnings from two different retinoic acid (RA)centered differentiation protocols, that in 4 days create homogenous populations of primitive endodermal and primitive neuroectodermal cells, respectively. Importantly, it is also inherent to this Rhosin setup that differentiationassociated changes to cell populace growth, measured by cell density, DNA synthesis and distribution in cell cycle phases, are comparable in both endodermal and ectodermal pathways. Experiments employing this design have led to the following findings: while cyclin A/ECDK2 activity correlate with cell populace growth parameters independently of differentiation status of cells, differences in cell fate are associated with presence of several types of molecular complex created by Dtype cyclins, CDK4, or CDK6 and p27. We assume Kl that this molecular diversity mirrors distinct functions of (i) CDK4 and CDK6, and (ii) individual Dtype cyclins, and that these molecules play a part in cell fate specification. == MATERIALS AND METHODS == == Cell culture == P19 EC cells (ATCC no. CRL1825) were cultured on gelatinized tissue dishes in Dulbecco’s altered Eagle’s medium (DMEM) made up of 10% foetal calf serum, 0.05 mmmercaptoethanol, 100 IU/mL penicillin, and 0.1 mg/mL streptomycin. Mouse ES cells (collection 10) and conditions for their culture have been explained previously (Bryjaet al. 2004b). To initiate differentiation, cells (5 103per cm2) were seeded onto gelatinized tissue culture dishes 12 h before application of experimental conditions. The cells were then cultured for 48 h in DMEM made up of 10% foetal calf serum or in DMEM/F12 (1 : 1) media supplemented with insulintransferrinselenium product (ITS) and antibiotics (further referred to as ITS medium) (all GibcoInvitrogen, Carlsbad, CA, USA) either in the presence or absence.